This early-stage company is developing soft, chewable versions of FDA-approved children’s medications: formats that are easier for kids to take and for parents to give. I joined the founding team as Chief Medical Officer, bringing a practicing pediatrician’s perspective to a problem any parent knows: getting a child to take a medication they need. My role runs from product decisions like taste masking, chew size, dosing, and the manufacturing partner through to fundraising, branding, retail strategy, and education, with a launch planned for summer 2027.

 

The Challenge:

Building a product that solves for both the child’s needs and the practical questions parents face when it’s time for a dose. Getting that right isn’t only a formulation problem. It takes real clinical judgment about how children actually take medication, what’s appropriate at different ages, and what will earn the trust of the pediatricians, retailers, and parents the product depends on. That’s where I came in: to bring a practicing pediatrician’s perspective to those decisions from the start.

 

The Solutions I Bring:

  • Medical consulting: As Chief Medical Officer, I bring a practicing pediatrician’s perspective to the product, with attention to children’s needs and the practical questions parents face when giving medication.
  • New product development: I help guide decisions on taste masking, chew size, dosing, and selecting a manufacturing partner.
  • Fundraising & launch strategy: I developed the pitch deck, met with investors, and advised on branding, product naming, and packaging.
  • Making valuable introductions: I help shape presentations to major retailers as we prepare for launch.
  • Medical education: I’m preparing educational resources for the pediatricians and consumers who will use the product.

The Results:

  • Product concept refined across taste, dosing, and format, with a manufacturing partner selected
  • Fundraising and investor outreach underway
  • Retail introduction and professional/consumer education in preparation
  • Launch planned for summer 2027
Scroll to Top